Abstract :

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia, and it represents a significant risk factor for the development and            progression  of  kidney disease. This review aims to elucidate the complex interplay between diabetes and kidney disease,  highlighting  the underlying  mechanisms, risk  factors, diagnostic  approaches,  and therapeutic interventions.

---

Keywords :

diabetes mellitus, hemodynamic, Hyperglycemia, kidney function, renal function

---

References :

1. Ritz E, Zeng XX,  Rychlik Clinical manifestation and natural history of diabetic nephropathy. Contrib. Nephrol. 2011; 170: 19-27. Doi: 10.1159/000324936.
2. Alicic RZ, Rooney MT,  Tuttle Diabetic  Kidney  Disease: Challenges,   Progress,    and Possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-2045. Doi: 10.2215/CJN.11491116.
3. American Diabetes (2021). Standards of Medical Care in Diabetes – 2021. Diabetes Care, 44(Supplement 1), S1-S232.
4. KDOǪI. (2020). KDOǪI Clinical   Practice  Guideline for Diabetes  and CKD: 2020   American Journal of   Kidney Diseases, 76(1), S1-S91.
5. De Boer, H., & Rue, T. C. (2021). Diabetic Nephropathy and Cardiovascular    Disease. Current Diabetes Reports, 21(7), 28.
6. Tuttle, R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein- Fuchs, J., … & Molitch, M. E. (2014). Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care, 37(10), 2864-2883.
7. Kanasaki K, Kitada M, Koya Pathophysiology of Diabetic Nephropathy: Experimental Findings and Therapeutic Implications. J Diabetes Res. 2017;2017:6078136. Doi: 10.1155/2017/6078136.
8. Fioretto P, Mauer Histopathology of diabetic nephropathy. Semin Nephrol. 2007;27(2):195-207. Doi: 10.1016/j.semnephrol.2007.01.008.
9. Molitch ME, DeFronzo RA,  Franz MJ, et Nephropathy in diabetes. Diabetes Care. 2004;27 Supply 1:S79-83. Doi: 10.2337/diacare.27.2007.s79.
10. Thomas MC, Brownlee M, Susztak K, et Diabetic kidney disease. Nat Rev Dis Primers. 2015;1:15018. Doi: 10.1038/nrdp.2015.18.
11. Kramer HJ, Nguyen ǪD, Curhan G, Hsu Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. JAMA. 2003; 289(24): 3273-3277. Doi: 10.1001/jama.289.24.3273.
12. Kanasaki, Keizo, and George L. King. “The role of advanced glycation end- products in the progression of diabetic ” Experimental diabetes    research 2011 (2011).
13. Fioretto, Paola, et “Molecular mechanisms and clinical pathophysiology of diabetic nephropathy.” Journal of the American Society of Nephrology 13.10 (2002): 2614-2625.
14. Sharma, , et al. “Diabetic kidney disease: the case for transforming growth factor-β as a key mediator.” Diabetes 44.10 (1995): 1139-1146.
15. Gnudi, Luigi, et “Mechanisms of tissue injury in diabetic nephropathy.” Journal of the American Society of Nephrology 27.4 (2016): 822-829.
16. Heerspink, J. L., & Perkins, B. A. (2019). Glucose Targets for Diabetic Kidney Disease: Time to Adjust Treatment Paradigms? Diabetes Care, 42(6), 989–992.
17. Colhoun, M., & Marcovecchio, M. L. (2019). Biomarkers of diabetic  kidney disease. Diabetologia, 62(6), 1015–1025. Alicic, R. Z., Rooney, M. T., & Tuttle, K. R. (2017).